SCHEMBL10260241

SCHEMBL10260241

CC[C@H]1O[C@@H](C)C(C)[C@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21214912 1.00 — —
SCHEMBL13899227 1.00 — —
SCHEMBL19263829 1.00 — —
SCHEMBL10260288 1.00 — —
SCHEMBL12300420 1.00 — —
SCHEMBL19263831 1.00 — —
SCHEMBL12746267 1.00 — —
SCHEMBL35361 1.00 — —
SCHEMBL15298329 0.97 — —
SCHEMBL13026644 0.97 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8586729-B2 Synthesis of decitabine SCINOPHARM TAIWAN LTD. (TW) 2013-11-19 — — US disclosed
US-8212021-B2 Process for making 5-azacytosine nucleosides and their derivatives SCINOPHARM TAIWAN, LTD. (TW) 2012-07-03 — — US disclosed
US-20100087637-A1 Synthesis of Decitabine SCINOPHARM TAIWAN LTD. 2010-04-08 — — US disclosed
US-20100036112-A1 Process for Making 5-Azacytosine Nucleosides and Their Derivatives SCINOPHARM TAIWAN LTD. 2010-02-11 — — US disclosed
US-7598230-B2 For the treatment of viral infections, microbial infections, and proliferative disorders; contain di- or triphosphate moeity mimetics, such as those containing boron anions BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2009-10-06 — — US disclosed
US-7285658-B2 Nucleotide mimics and their prodrugs BIOTA, INC. (US) 2007-10-23 — — US disclosed
Send feedback